Internal Medicine, Pulmonary Disease · Ann Arbor, MI
NPI
1437231347
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 E Medical Center Dr
Ann Arbor, MI, 48109
Phone (734) 936-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
809 services
Medicare patients, 2024
300
Average age 71
Drug cost, 2024
$1.6M
819 prescriptions
Company payments, 2023
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert C Hyzy was code 94010 (pulmonary function testing), 151 times for 139 patients. In total Robert C Hyzy billed 809 services in 25 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94010 Pulmonary Function Testing | Facility | 151 | 139 | $5.90 | $891 |
| 94729 Pulmonary Function Testing | Facility | 134 | 125 | $6.33 | $848 |
| 99291 Critical Care E&M | Facility | 130 | 40 | $167.36 | $22K |
| 94729 Pulmonary Function Testing | Office | 51 | 50 | $5.91 | $302 |
| 94010 Pulmonary Function Testing | Office | 50 | 49 | $5.35 | $268 |
| 99214 Office E&M - Established | Facility | 43 | 39 | $72.90 | $3,135 |
| 94618 Pulmonary Function Testing | Facility | 28 | 27 | $15.43 | $432 |
| 99205 Office E&M - New | Facility | 26 | 26 | $137.52 | $3,575 |
| 94726 Pulmonary Function Testing | Facility | 21 | 21 | $8.18 | $172 |
| 99214 Office E&M - Established | Office | 20 | 19 | $75.31 | $1,506 |
| 94060 Pulmonary Function Testing | Facility | 16 | 16 | $7.48 | $120 |
| 99215 Office E&M - Established | Facility | 15 | 14 | $114.71 | $1,721 |
| 99215 Office E&M - Established | Office | 15 | 14 | $100.39 | $1,506 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 12 | 12 | $13.14 | $158 |
| 94726 Pulmonary Function Testing | Office | 12 | 12 | $7.63 | $91.55 |
By year: 2022 $48K for 1,111 services; 2023 $53K for 1,040 services; 2024 $42K for 809 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert C Hyzy prescribed most often to Medicare patients was Prednisone, with 99 prescriptions and refills. In total Robert C Hyzy wrote 819 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 99 | 150 | 25 | $605 |
| Ofev Nintedanib Esylate | 86 | 86 | Under 11 | $1.1M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 52 | 58 | 25 | $2,191 |
| Pirfenidone Generic | 49 | 49 | Under 11 | $80K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 46 | 54 | 12 | $10K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 45 | 67 | 11 | $7,410 |
| Spiriva Respimat Tiotropium Bromide | 34 | 46 | Under 11 | $28K |
| Breo Ellipta Fluticasone/Vilanterol | 25 | 33 | Under 11 | $12K |
| Symbicort Budesonide/Formoterol Fumarate | 24 | 42 | Under 11 | $8,864 |
| Esbriet Pirfenidone | 24 | 24 | Under 11 | $246K |
| Methotrexate Methotrexate Sodium | 23 | 39 | Under 11 | $440 |
| Mycophenolate Mofetil Generic | 21 | 49 | Under 11 | $5,443 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 21 | 47 | Under 11 | $5,249 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 21 | 21 | Under 11 | $13K |
| Incruse Ellipta Umeclidinium Bromide | 19 | 27 | Under 11 | $9,022 |
Brand drugs: 440 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Robert C Hyzy $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.